Farallon Capital Management LLC Intra Cellular Therapies, Inc. Transaction History
Farallon Capital Management LLC
- $17.4 Billion
- Q1 2025
A detailed history of Farallon Capital Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,055,000 shares of ITCI stock, worth $403 Million. This represents 2.32% of its overall portfolio holdings.
Number of Shares
3,055,000Holding current value
$403 Million% of portfolio
2.32%Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
68.1MCall Options Held
934KPut Options Held
758K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Ubs Oconnor LLC Chicago, IL3.09MShares$408 Million28.36% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.26MShares$298 Million0.52% of portfolio
-
Deep Track Capital, LP Greenwich, CT2MShares$264 Million9.22% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...